PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24527N0037Radiopharmaceuticals — Jubilant Draximage Radiopharmacies, Inc

Jubilant Draximage Radiopharmacies, Inc holds $14.3M across 85 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C24525A0001. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

245-Network Contract Office 5 (36C245)

Awarding office

Jubilant Draximage Radiopharmacies, Inc

Recipient

Sep 30, 2027

PoP end

$618K

Obligated

$618K

Potential

325412

NAICS

6505

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number36C24527N0037

Also listed as36C245-27-N-0037

Also listed as36C24525A0001-36C24527N0037

Agency245-Network Contract Office 5 (36C245)

Awarding office245-Network Contract Office 5 (36C245)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentJubilant Draximage Radiopharmacies, Inc

CAGE7YPV6

UEIZL79MXYVNDM1

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36C24525A0001

Place of performancePEACHTREE CORNERS GA

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startOct 1, 2026

PoP end (current)Sep 30, 2027

Obligated$618K

Current value$618K

Potential value$618K

Radiopharmaceuticals is a federal Unrestricted award for 245-Network Contract Office 5 (36C245) held by Jubilant Draximage Radiopharmacies, Inc. Estimated value $618K ($618K obligated). Current period of performance ends Sep 30, 2027. Last award drew 1 bidder. Place of performance: PEACHTREE CORNERS GA.

Recompete timing

Public

● Expiring in 348 days

Current PoP ends Sep 30, 2027 (348 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 36C24527N0037? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Jubilant Draximage Radiopharmacies, Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($14.3M) · all agencies

Department of Veterans Affairs (VA)$14.1M · 99%Department of Defense (DOD)$157K · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C24426N0280

IOFLUPANE - BRAND NAME OR EQUAL

$132K

Jan 16, 2027

W81K0226FA029

RADIOPHARMACEUTICALS MAMC

$157K

Jan 30, 2027

36C25626N0346

NUCLEAR MEDICINE IMAGING RADIO-THERAPEUTIC ISOTOPES

$363K

Feb 28, 2027

36C24626N0541

RADIOPHARMACEUTICALS

$522K

Mar 4, 2027

36C25226N0364

RADIOPHARM OY 1: 04/01/2026 - 03/31/207

$200K

Mar 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24527N0037?

36C24527N0037 (Radiopharmaceuticals) is a 245-Network Contract Office 5 (36C245) award with a potential value of $618K, currently held by Jubilant Draximage Radiopharmacies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C245-27-N-0037?

36C245-27-N-0037 is the dashed form of PIID 36C24527N0037 (Radiopharmaceuticals), held by Jubilant Draximage Radiopharmacies, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24527N0037?

245-Network Contract Office 5 (36C245) awarded 36C24527N0037 to Jubilant Draximage Radiopharmacies, Inc (potential $618K).

Who is the incumbent on 36C24527N0037?

Jubilant Draximage Radiopharmacies, Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.

When does Jubilant Draximage Radiopharmacies, Inc’s 36C24527N0037 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24527N0037? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Oct 1, 2026